ReviewPost screenProgress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites

Add time:08/22/2019    Source:sciencedirect.com

Technetium-99m (Tc-99m) has long been a mainstay in clinical nuclear medicine, primarily monitoring biological processes in the heart, kidney, liver, and brain. More recently, Tc-99m chelates have been used as the reporter in targeted nuclear medicine probes that monitor changes in specific protein expression products. The strengths remain the inexpensive source of Tc-99m from the Mo-99/Tc-99m generator, its rich chemistry, high-yield kit formulation, and its widespread availability. Hardware and software advances, such as OSEM reconstructions with scatter and attenuation corrections, have led to quantitation of the injected radioactivity in terms of kBq/cm.

We also recommend Trading Suppliers and Manufacturers of technetium Tc 99m teboroxime (cas 104716-22-5). Pls Click Website Link as below: cas 104716-22-5 suppliers

Prev:The 4-tert-butylphenyl group as a simple tag for solution phase synthesis
Next:ReviewApplication of corrosion inhibitors for steels in acidic media for the oil and gas industry: A review)